Browsing by Author "Rocha, Hugo"
Now showing 1 - 6 of 6
Results Per Page
Sort Options
- Cardiac molecular remodeling by anticancer drugs: Doxorubicin affects more metabolism while mitoxantrone impacts more autophagy in adult CD-1 male micePublication . Brandão, Sofia Reis; Reis-Mendes, Ana; Duarte-Araújo, Margarida; Neuparth, Maria João; Rocha, Hugo; Carvalho, Félix; Ferreira, Rita; Costa, Vera MarisaDoxorubicin (DOX) and mitoxantrone (MTX) are classical chemotherapeutic agents used in cancer that induce similar clinical cardiotoxic effects, although it is not clear if they share similar underlying molecular mechanisms. We aimed to assess the effects of DOX and MTX on the cardiac remodeling, focusing mainly on metabolism and autophagy. Adult male CD-1 mice received pharmacologically relevant cumulative doses of DOX (18 mg/kg) and MTX (6 mg/kg). Both DOX and MTX disturbed cardiac metabolism, decreasing glycolysis, and increasing the dependency on fatty acids (FA) oxidation, namely, through decreased AMP-activated protein kinase (AMPK) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) content and decreased free carnitine (C0) and increased acetylcarnitine (C2) concentration. Additionally, DOX heavily influenced glycolysis, oxidative metabolism, and amino acids turnover by exclusively decreasing phosphofructokinase (PFKM) and electron transfer flavoprotein-ubiquinone oxidoreductase (ETFDH) content, and the concentration of several amino acids. Conversely, both drugs downregulated autophagy given by the decreased content of autophagy protein 5 (ATG5) and microtubule-associated protein light chain 3 (LC3B), with MTX having also an impact on Beclin1. These results emphasize that DOX and MTX modulate cardiac remodeling differently, despite their clinical similarities, which is of paramount importance for future treatments.
- Desenvolvimento e implementação de técnicas para deteção de alergénios nos alimentosPublication . Santos, Andreia; Rocha, Hugo; Lopes, Maria; Lamas, Maria Céu; Mota, Sandra; Gomes, António; Sousa, MariaOs alergénios alimentares são antigénios que provocam hipersensibilidades ou reações alérgicas nos indivíduos. Pequenas quantidades de um alergénio podem instigar uma cascata de reações imunológicas, mediadas por imunoglobulinas e, em casos graves, culminar na morte. Por esta razão, são considerados preponderantes para a segurança alimentar, dado que a frequência dessas reações tem aumentado a nível mundial. O processamento de alimentos pode aumentar o caráter alergénico dos alimentos, devido a alterações na estrutura e propriedades das proteínas, pelo que a rotulagem dos produtos depende de métodos sensíveis e específicos para a deteção de alergénios.
- Dried blood spots in clinical lipidomics: optimization and recent findingsPublication . Ferreira, Helena Beatriz ; Guerra, Inês M. S. ; Melo, Tânia ; Rocha, Hugo; Moreira, Ana S. P. ; Paiva, Artur ; Domingues, M. RosárioDried blood spots (DBS) are being considered as an alternative sampling method of blood collection that can be used in combination with lipidomic and other omic analysis. DBS are successfully used in the clinical context to collect samples for newborn screening for the measurement of specifc fatty acid derivatives, such as acylcarnitines, and lipids from whole blood for diagnostic purposes. However, DBS are scarcely used for lipidomic analysis and investigations. Lipidomic stud ies using DBS are starting to emerge as a powerful method for sampling and storage in clinical lipidomic analysis, but the major research work is being done in the pre- and analytical steps and procedures, and few in clinical applications. This review presents a description of the impact factors and variables that can afect DBS lipidomic analysis, such as the type of DBS card, haematocrit, homogeneity of the blood drop, matrix/chromatographic efects, and the chemical and physi cal properties of the analyte. Additionally, a brief overview of lipidomic studies using DBS to unveil their application in clinical scenarios is also presented, considering the studies of method development and validation and, to a less extent, for clinical diagnosis using clinical lipidomics. DBS combined with lipidomic approaches proved to be as efective as whole blood samples, achieving high levels of sensitivity and specifcity during MS and MS/MS analysis, which could be a useful tool for biomarker identifcation. Lipidomic profling using MS/MS platforms enables signifcant insights into physiological changes, which could be useful in precision medicine.
- Lipid profile variability in children at different ages measured in dried blood spotsPublication . Ferreira, Helena Beatriz; Melo, Tânia; Rocha, Hugo; Paiva, Artur; Domingues, Pedro; Domingues, M. RosárioDried blood spot (DBS) is a minimally invasive sampling technique that has several advantages over conventional venipuncture/arterial blood sampling. More recently, DBS has also been applied for lipidomics analysis, but this is an area that requires further research. The few works found in the literature on lipidomics of DBS samples performed the analysis in adult samples, leaving pediatric ages unmapped. The objective of this study was to assess the variability of the lipid profile (identified by high-resolution C18 RP-LC-MS/MS) of DBS at pediatric age (0-10 days, 2-18 months, and 3-13 years) and to identify age-related variations. The results revealed that the lipidomic signature of the three age groups is significantly different, especially for a few species of neutral lipids and phosphatidylcholines. The main contributors to the differentiation of the groups correspond to 3 carnitine (Car), 2 cholesteryl ester (CE), 2 diacylglycerol (DG), 2 triacylglycerol (TG), 3 phosphatidylcholine (PC), 1 ether-linked PC, 1 phosphatidylethanolamine (PE), 1 ether-linked PE and 1 phosphatidylinositol (PI) species, all with statistically significant differences. Additionally, lipid species containing linoleic acid (C18:2) were shown to have significantly lower levels in the 0-10 days group with a gradual increase in the 2-18 month, reaching the highest concentrations in the 3-13 year group. The results of this study highlighted the adaptations of the lipid profile at different pediatric ages. These results may help improve understanding of the evolution of lipid metabolism throughout childhood and should be investigated further.
- Mitochondrial fatty acid β-oxidation disorders: from disease to lipidomic studies—a critical reviewPublication . Guerra, Inês M. S.; Ferreira, Helena B.; Melo, Tânia; Rocha, Hugo; Moreira, Sónia; Diogo, Luísa; Domingues, Maria Rosário; Moreira, Ana S. P.Fatty acid oxidation disorders (FAODs) are inborn errors of metabolism (IEMs) caused by defects in the fatty acid (FA) mitochondrial β-oxidation. The most common FAODs are characterized by the accumulation of medium-chain FAs and long-chain (3-hydroxy) FAs (and their carnitine derivatives), respectively. These deregulations are associated with lipotoxicity which affects several organs and potentially leads to life-threatening complications and comorbidities. Changes in the lipidome have been associated with several diseases, including some IEMs. In FAODs, the alteration of acylcarnitines (CARs) and FA profiles have been reported in patients and animal models, but changes in polar and neutral lipid profile are still scarcely studied. In this review, we present the main findings on FA and CAR profile changes associated with FAOD pathogenesis, their correlation with oxidative damage, and the consequent disturbance of mitochondrial homeostasis. Moreover, alterations in polar and neutral lipid classes and lipid species identified so far and their possible role in FAODs are discussed. We highlight the need of mass-spectrometry-based lipidomic studies to understand (epi)lipidome remodelling in FAODs, thus allowing to elucidate the pathophysiology and the identification of possible biomarkers for disease prognosis and an evaluation of therapeutic efficacy
- Molecular techniques for the neonatal screening of spinal muscular atrophyPublication . Oliveira, Renata; Granja, Sara; Silva, Regina A.; Rocha, HugoSpinal muscular atrophy (SMA) is neurodegenerative disease mainly caused by the homozygous deletion of the functional telomeric survival motor neuron 1 gene (SMN1) exon 7. This absence causes a lack of the ubiquitous SMN protein which selectively destroys alfa motor neurons. Due to the disease severity, it is the leading genetic cause of infant death. The copy number of the centromeric SMN2 gene has an inverse correlation with the phenotype. SMA is currently classified in 5 types – Type 0 (lethal in womb or in the first weeks of life), Type I (approximately 50% of cases), Type 2 (children can sit alone), Type 3 (children can walk independently) and Type 4 (mildest form that appears in adults). Diagnosis is only made when symptoms arise and, by then, motor neurons are already irreversibly lost. Three therapies are now available, but they are most effective in the asymptomatic phase. To achieve this objective, the strategy is to include SMA in the panel of diseases screened in the Neonatal Screening (NS) Programs. In this sense, we describe the implementation of an in-house assay, that detects the absence of exon 7 of the SMN1 gene through the real-time polymerase chain reaction technique, adapted to NS. Normal controls and pathological samples collected from Guthrie cards were used. Our results show 100% concordance with the known genotypes (100% sensitivity and specificity). This method is a reliable, simple and affordable way to screen for this lethal disease.